Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) and HMC HealthWorks Enter Sales and Distribution Partnership

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital-therapeutics market, together with HMC HealthWorks, a 40-year veteran in health-care management with clinically-integrated models of care that reduce health-care costs and improve population health, today announced entry into a sales and distribution agreement. Under the partnership, HMC will incorporate DarioHealth’s digital therapeutics solution into its care management programs on a stand-alone basis as well as for incorporation within HMC’s comprehensive solutions. “We believe that this agreement with HMC is further validation of the progress we have made in transitioning to a leading provider of digital-therapeutics solutions to payors, employers and other at-risk entities with a desire to help their members manage their chronic conditions and improve their clinical outcomes,” said Rick Anderson, president and general manager of North America at DarioHealth, in the press release. “We are pleased to partner with HMC, who has a long history of providing innovative solutions to their customers.  This agreement expands our distribution of our solutions, and we are already building a pipeline within HMC’s vast client base, which we believe speaks to the tangible results that we bring to patients and payers alike.”

To view the full press release, visit https://ibn.fm/lSFcN

About DarioHealth Corp.

DarioHealth Corp. (NASDAQ: DRIO) is a leading, global digital-therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, DarioHealth empowers individuals to make adjustments to their daily lifestyle choices to improve their overall health. Its cross-functional team operates at the intersection of life and behavioral sciences and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario(TM) mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease. To learn more about the company and its digital health solutions, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO  

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

This entry was posted in DarioHealth Corp. DRIO, MissionIRNewsBreaks. Bookmark the permalink.

Comments are closed.